News & events
News and events
-
Event /
Standard Model Joins the Jefferies Global Healthcare Conference in London
CEO and Cofounder Kevin Brown will be at the Jefferies Global Healthcare Conference in London, November 16–19 at The Waldorf Hilton. Contact us to schedule a meeting.
-
Video /
Watch: Brian Schilder Presents CuEvo and hg-horizon at CSHL Biological Data Science
In his Cold Spring Harbor talk, AI Scientist Brian Schilder shows how CuEvo computes all 70 trillion variant pairs across the two largest human chromosomes in 14 minutes on a single GPU, and what hg-horizon revealed once every pair was visible.
-
Blog Post /
Listen: A Simulated Conversation About Simulating Patients
Two AI-generated hosts unpack how the Standard Model forecasts disease progression, how it performed in Protege’s double-blind evaluation at a fraction of frontier-model cost, and what TrialFront means for clinical trial design.
-
Event /
Standard Model Joins ARPA-H’s SURPASS Program Proposers’ Day
Standard Model is excited to be participating in ARPA-H’s SURPASS Program Proposers’ Day on November 6, featuring Ryan Shewcraft, Head of Data Science.
-
Event / / Cold Spring Harbor, N.Y.
Standard Model Biomedicine to Present GPU-Accelerated Genomics Tools at CSHL Biological Data Science Meeting
Brian Schilder will present “Exploring the genome at every scale” on November 6, covering GPU-accelerated tools for genome-wide interaction calculations and visualization.
-
Press Release /
Standard Model Joins Protege’s Launch of Independent Double-Blind Evaluations
In Protege’s double-blind test on breast and lung cancer, the Standard Model performed competitively with frontier models at 36 to 170 times lower cost per prediction.
-
Blog Post /
Benchmarking the Frontiers on Cancer
On lung cancer, the Standard Model posted the highest headline score of any model tested, and on breast cancer was within the 95% confidence intervals of frontier models.
-
Event / / Virtual
Kevin Brown Joins Flare Capital’s Expert Roundtable on Agentic AI Infrastructure in Healthcare
Standard Model Biomedicine CEO and Cofounder Kevin Brown joins agent-infrastructure founders, frontier-lab researchers, and health system and life sciences operators to discuss what it takes to move AI agents from demos to production — from post-training and agentic harnesses to the emerging role of world models in simulation and prediction.
-
Blog Post /
Zero Shot Results: Standard Model Answered the Toughest Clinical Questions Without Ever Being Trained.
SMB released the first version of the Standard Model, a JEPA multimodal, multi-scale world model, releasing the first look at our capabilities to build a universal patient representation, “A Multidimensional Biological Reasoning Engine”. One of the best and most difficult ways to test a world model is by zero shot inference, “Can the model predict outcomes or draw conclusions from patients it has never seen before?” That’s the Billion Dollar Question.
-
Company Blog Post /
Celebrating Dr. David Laub – PhD Defense: Scaling Biological Sequence Models at Standard Model Biomedicine
David’s doctoral research addresses one of the fundamental barriers in computational genomics—the massive data storage and loading bottlenecks that hinder training deep learning models on personalized genomes. Through his PhD work and his key contributions at SMB, David is fundamentally changing how biobank-scale genomic data is ingested and modeled. David led key Computational Breakthroughs at UCSD: GenVarLoader & GenVarFormer.
-
Company /
Standard Model Biomedicine Appoints Julie Gerardi to Lead Business Development and Strategy
Biotech commercial veteran Julie Gerardi joins Standard Model to lead commercial strategy, go-to-market, and strategic partnerships — bringing 25+ years scaling life science companies from Bioptimus to Tempus AI and Parse Biosciences.









